Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
The approval bolsters the company's Mycophenolate Mofetil portfolio
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Eris Lifesciences enters into term loan agreement with Citi Bank
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Subscribe To Our Newsletter & Stay Updated
